Interleukin-28B Polymorphisms Predict the Efficacy of Peginterferon Alpha in Patients With Chronic Hepatitis B: A Meta-Analysis

Background: Polyethylene glycol interferon alpha (PEG-IFN-α) is the most frequently used pharmacotherapeutic approach in patients infected with hepatitis B virus (HBV). Numerous studies have reported that interleukin-28B (IL-28B) genetic polymorphisms are related to the therapeutic efficacy of PEG-I...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Sang-Yu, Hu, Yao-Ren, Gao, Guo-Sheng, Lou, Ke-Hong, Huang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298999/
https://www.ncbi.nlm.nih.gov/pubmed/34307418
http://dx.doi.org/10.3389/fmed.2021.691365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298999/
https://www.ncbi.nlm.nih.gov/pubmed/34307418
http://dx.doi.org/10.3389/fmed.2021.691365

Ejemplares similares